We are live on
!
Find out more
Bristol-Myers Squibb
BMY
BMY
2,147 hedge funds and large institutions have $63.8B invested in Bristol-Myers Squibb in 2024 Q2 according to their latest regulatory filings, with 170 funds opening new positions, 688 increasing their positions, 1,046 reducing their positions, and 321 closing their positions.
New
Increased
Maintained
Reduced
Closed
9% less call options, than puts
Call options by funds: $1.51B | Put options by funds: $1.65B
1.32% less ownership
Funds ownership: 77.09% → 75.77% (-1.3%)
8% less funds holding
Funds holding: 2,331 → 2,147 (-184)
10% less funds holding in top 10
Funds holding in top 10: 20 → 18 (-2)
24% less capital invested
Capital invested by funds: $84.5B → $63.8B (-$20.7B)
34% less repeat investments, than reductions
Existing positions increased: 688 | Existing positions reduced: 1,046
47% less first-time investments, than exits
New positions opened: 170 | Existing positions closed: 321
Holders
2,147
Holders Change
-184
Holders Change %
-7.89%
% of All Funds
31.01%
Holding in Top 10
18
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-10%
% of All Funds
0.26%
New
170
Increased
688
Reduced
1,046
Closed
321
Calls
$1.51B
Puts
$1.65B
Net Calls
-$144M
Net Calls Change
-$471M
Top Buyers
| 1 |
Citadel Advisors
Miami,
Florida
|
+$477M |
| 2 |
Charles Schwab
San Francisco,
California
|
+$239M |
| 3 |
UBS AM
Chicago,
Illinois
|
+$173M |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$156M |
| 5 |
Squarepoint
New York
|
+$154M |
Top Sellers
| 1 |
Capital International Investors
Los Angeles,
California
|
-$662M |
| 2 |
JP Morgan Chase
New York
|
-$635M |
| 3 |
Boston Partners
Boston,
Massachusetts
|
-$314M |
| 4 |
Franklin Resources
San Mateo,
California
|
-$259M |
| 5 |
N
Nuveen
Charlotte,
North Carolina
|
-$197M |
